(Q35079273)

6 August 2017

1 reference

title

Extracorporeal photochemoimmunotherapy in cutaneous T-cell lymphoma (English)

1 reference

6 August 2017

Knobler R

1

1 reference

PubMed ID

12620272

6 August 2017

Jantschitsch C

series ordinal

2

1 reference

6 August 2017

1 February 2003

1 reference

Transfusion and Apheresis Science

6 August 2017

1 reference

6 August 2017

28

1 reference

6 August 2017

1

1 reference

6 August 2017

81-89

1 reference

Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Parenteral administration of 8-methoxypsoralen in photopheresis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Cutaneous T cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Photopheresis--extracorporeal irradiation of 8-MOP containing blood--a new therapeutic modality

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Inhibition of autoimmune disease in a murine model of systemic lupus erythematosus induced by exposure to syngeneic photoinactivated lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

The immune response to class I-associated tumor-specific cutaneous T-cell lymphoma antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Cell membrane DNA: a new target for psoralen photoadduct formation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Extracorporeal photochemotherapy induces the production of tumor necrosis factor-alpha by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Monoclonal antibodies to DNA modified by 8-methoxypsoralen and ultraviolet A light

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Increased surface expression of class I MHC molecules on immunogenic cells derived from the xenogenization of P815 mastocytoma cells with 8-methoxypsoralen and long-wavelength ultraviolet radiation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Extracorporeal photochemotherapy in patients with steroid-dependent Crohn's disease: a prospective pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Release of Oxygen-Free Radicals by Neutrophils Is Reduced by Photopheresis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

An animal model for extracorporeal photochemotherapy based on contact hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Suppression of anti-skin-allograft response by photodamaged effector cells--the modulating effects of prednisolone and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Combined therapy for Sézary syndrome with extracorporeal photochemotherapy and low-dose interferon alfa therapy. Clinical, molecular, and immunologic observations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Photopheresis therapy for cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Long-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

The sign of Leser-Trélat in association with Sézary syndrome: simultaneous disappearance of seborrheic keratoses and malignant T-cell clone during combined therapy with photopheresis and interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Cutaneous cryptococcosis in a patient with cutaneous T cell lymphoma receiving therapy with photopheresis and methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Extracorporeal photopheresis in cutaneous T-cell lymphoma. Inconsistent data underline the need for randomized studies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Photopheresis: clinical applications and mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Extracorporeal photopheresis in Sézary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Role of extracorporeal photochemotherapy alone and in combination with interferon alfa in the treatment of cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Extracorporeal photopheresis and recombinant interferon alfa 2b in Sezary syndrome. Use of dual marker labeling to monitor therapeutic response

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Extracorporeal photopheresis and interferon-alpha in advanced cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Long-term follow-up in 51 patients with mycosis fungoides and Sézary syndrome treated by interferon-alfa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Durable loss of a malignant T-cell clone in a stage IV cutaneous T-cell lymphoma patient treated with high-dose interferon and photopheresis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Evidence is lacking for a synergistic or additive effect of combination extracorporeal photopheresis with interferon alfa for cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Photoactivated 8-methoxypsoralen treatment causes a peptide-dependent increase in antigen display by transformed lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Tumor-specific peptides in cutaneous T-cell lymphoma: association with class I major histocompatibility complex and possible derivation from the clonotypic T-cell receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Induction of human tumor-loaded dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Extracorporeal photochemotherapy for cutaneous T-cell lymphoma: a 9.7-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma--the Düsseldorf and Munich experience

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

[Therapeutic experiences with extracorporeal photopheresis. Technical procedure, follow-up and clinical outcome in 31 skin diseases]

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Extracorporeal photopheresis of cutaneous T-cell lymphoma is associated with reduction of peripheral CD4+ T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

Transimmunization and the evolution of extracorporeal photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-0502%2802%2900103-9

7 January 2021

10.1016/S1473-0502(02)00103-9

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12620272